- Home
- APM vs PAVM Comparison
APM vs PAVM Comparison
Compare APM & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APM | PAVM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | 107 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 8.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | APM | PAVM |
|---|---|---|
| Price | $0.81 | $9.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 45.1K | ★ 156.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.21 |
| 52 Week High | $4.47 | $28.44 |
Technical Indicators
Market Signals| Indicator | APM | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 49.53 |
| Support Level | $0.78 | $0.39 |
| Resistance Level | $1.11 | $9.26 |
| Average True Range (ATR) | 0.07 | 1.04 |
| MACD | 0.01 | -0.40 |
| Stochastic Oscillator | 65.11 | 11.57 |
Price Performance
Historical ComparisonAbout APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.